The Rheumatoid Arthritis-Associated Citrullinome.

Increased protein citrullination is linked to various diseases including rheumatoid arthritis (RA), lupus, and cancer. Citrullinated autoantigens, a hallmark of RA, are recognized by anti-citrullinated protein antibodies (ACPAs) which are used to diagnose RA. ACPA-recognizing citrullinated enolase, vimentin, keratin, and filaggrin are also pathogenic. Here, we used a chemoproteomic approach to define the RA-associated citrullinome. The identified proteins include numerous serine protease inhibitors (Serpins), proteases and metabolic enzymes. We demonstrate that citrullination of antiplasmin, antithrombin, t-PAI, and C1 inhibitor (P1-Arg-containing Serpins) abolishes their ability to inhibit their cognate proteases. Citrullination of nicotinamide N-methyl transferase (NNMT) also abolished its methyltransferase activity. Overall, these data advance our understanding of the roles of citrullination in RA and suggest that extracellular protein arginine deiminase (PAD) activity can modulate protease activity with consequent effects on Serpin-regulated pathways. Moreover, our data suggest that inhibition of extracellular PAD activity will be therapeutically relevant.

[1]  James T. Elder,et al.  Novel multiplex technology for diagnostic characterization of rheumatoid arthritis , 2011, Arthritis research & therapy.

[2]  P. Casaccia‐Bonnefil,et al.  Post-Translational Modifications of Nucleosomal Histones in Oligodendrocyte Lineage Cells in Development and Disease , 2008, Journal of Molecular Neuroscience.

[3]  N. Greene,et al.  Protein deiminases: new players in the developmentally regulated loss of neural regenerative ability. , 2011, Developmental biology.

[4]  G. Pruijn,et al.  The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and β-actin. , 2013, Arthritis and rheumatism.

[5]  J. Hodgin,et al.  Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice , 2014, Annals of the rheumatic diseases.

[6]  M. Inagaki,et al.  Ca2+-dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain. , 1989, The Journal of biological chemistry.

[7]  B. Cravatt,et al.  Tandem orthogonal proteolysis-activity-based protein profiling (TOP-ABPP)—a general method for mapping sites of probe modification in proteomes , 2007, Nature Protocols.

[8]  Pojen P. Chen,et al.  NETs Are a Source of Citrullinated Autoantigens and Stimulate Inflammatory Responses in Rheumatoid Arthritis , 2013, Science Translational Medicine.

[9]  R. Wait,et al.  Identification of citrullinated α-enolase as a candidate autoantigen in rheumatoid arthritis , 2005, Arthritis research & therapy.

[10]  J. Whisstock,et al.  Antithrombin: in control of coagulation. , 2004, The international journal of biochemistry & cell biology.

[11]  P. Taylor,et al.  A Systematic Review of Serum Biomarkers Anti-Cyclic Citrullinated Peptide and Rheumatoid Factor as Tests for Rheumatoid Arthritis , 2011, Autoimmune diseases.

[12]  P. Thompson,et al.  Detection and identification of protein citrullination in complex biological systems. , 2016, Current opinion in chemical biology.

[13]  C. Kluft,et al.  Plasminogen activator inhibitors. , 1987, Blood.

[14]  K. Su,et al.  Neutrophil Extracellular Traps and Systemic Lupus Erythematosus. , 2013, Journal of clinical & cellular immunology.

[15]  Jinxiang Han,et al.  Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors , 2006, Molecular carcinogenesis.

[16]  G. Pruijn,et al.  Demonstration of extracellular peptidylarginine deiminase (PAD) activity in synovial fluid of patients with rheumatoid arthritis using a novel assay for citrullination of fibrinogen , 2014, Arthritis Research & Therapy.

[17]  R. Krüger,et al.  Diverse stimuli engage different neutrophil extracellular trap pathways , 2017, eLife.

[18]  R. Schasfoort,et al.  Mapping of citrullinated fibrinogen B-cell epitopes in rheumatoid arthritis by imaging surface plasmon resonance , 2010, Arthritis research & therapy.

[19]  R. Parsons,et al.  A Rapid and Efficient Assay for the Characterization of Substrates and Inhibitors of Nicotinamide N-Methyltransferase. , 2016, Biochemistry.

[20]  E. Vossenaar,et al.  Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis , 2004, Arthritis research & therapy.

[21]  R. Law,et al.  Contribution of Conserved Lysine Residues in the α2-Antiplasmin C Terminus to Plasmin Binding and Inhibition* , 2011, The Journal of Biological Chemistry.

[22]  S. L. Carpenter,et al.  α2‐Antiplasmin and its deficiency: fibrinolysis out of balance , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[23]  F. Mastronardi,et al.  The Role of Citrullinated Proteins Suggests a Novel Mechanism in the Pathogenesis of Multiple Sclerosis , 2006, Neurochemical Research.

[24]  H. Christofk,et al.  Pyruvate kinase M2 is a phosphotyrosine-binding protein , 2008, Nature.

[25]  B. Fleckenstein,et al.  Specific biotinylation and sensitive enrichment of citrullinated peptides , 2013, Analytical and Bioanalytical Chemistry.

[26]  P. Pissios.  Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme , 2017, Trends in Endocrinology & Metabolism.

[27]  Yanming Wang,et al.  Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis. , 2013, Biochimica et biophysica acta.

[28]  A. Ishigami,et al.  Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease , 2005, Journal of neuroscience research.

[29]  P. Agostinis,et al.  Citrullinated Glucose-Regulated Protein 78 Is an Autoantigen in Type 1 Diabetes , 2014, Diabetes.

[30]  J. Yates,et al.  DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. , 2002, Journal of proteome research.

[31]  K. Preissner,et al.  Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activator. , 1991, The Journal of biological chemistry.

[32]  A. Chumanevich,et al.  Seeing citrulline: development of a phenylglyoxal-based probe to visualize protein citrullination. , 2012, Journal of the American Chemical Society.

[33]  P. Thompson,et al.  Activation of PAD4 in NET formation , 2012, Front. Immun..

[34]  R. Bamezai,et al.  Human pyruvate kinase M2: A multifunctional protein , 2010, Protein science : a publication of the Protein Society.

[35]  Poonam Singh,et al.  Serpin Inhibition Mechanism: A Delicate Balance between Native Metastable State and Polymerization , 2011, Journal of amino acids.

[36]  A. Nicholas.  Dual immunofluorescence study of citrullinated proteins in Parkinson diseased substantia nigra , 2011, Neuroscience Letters.

[37]  R. Zubarev,et al.  Release of Active Peptidyl Arginine Deiminases by Neutrophils Can Explain Production of Extracellular Citrullinated Autoantigens in Rheumatoid Arthritis Synovial Fluid , 2015, Arthritis & rheumatology.

[38]  J. Yates,et al.  An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database , 1994, Journal of the American Society for Mass Spectrometry.

[39]  Remco Loos,et al.  Citrullination regulates pluripotency and histone H1 binding to chromatin , 2014, Nature.

[40]  E. Lapointe,et al.  Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin , 2004, Arthritis research & therapy.

[41]  R. Wait,et al.  Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. , 2008, Arthritis and rheumatism.

[42]  B. Stoddard,et al.  The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate. , 1998, Structure.

[43]  M. Cicardi,et al.  Mechanisms of C1-inhibitor deficiency. , 2002, Immunobiology.

[44]  A. Navratil,et al.  GnRH Stimulates Peptidylarginine Deiminase Catalyzed Histone Citrullination in Gonadotrope Cells. , 2016, Molecular endocrinology.

[45]  P. Thompson,et al.  Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential. , 2009, Current opinion in drug discovery & development.

[46]  E. Vossenaar,et al.  PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[47]  F. Breedveld,et al.  Aspects of early arthritis. Definition of disease states in early arthritis: remission versus minimal disease activity , 2006, Arthritis research & therapy.

[48]  B. Cravatt,et al.  NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink , 2013, Nature chemical biology.

[49]  C. Esmon,et al.  Structure of the antithrombin–thrombin–heparin ternary complex reveals the antithrombotic mechanism of heparin , 2004, Nature Structural &Molecular Biology.

[50]  G. Silverman,et al.  Squamous Cell Carcinoma Antigen 2 Is a Novel Serpin That Inhibits the Chymotrypsin-like Proteinases Cathepsin G and Mast Cell Chymase* , 1997, The Journal of Biological Chemistry.

[51]  W. Robinson,et al.  N-α-Benzoyl-N5-(2-Chloro-1-Iminoethyl)-l-Ornithine Amide, a Protein Arginine Deiminase Inhibitor, Reduces the Severity of Murine Collagen-Induced Arthritis , 2011, The Journal of Immunology.

[52]  Jinxiang Han,et al.  Increased PADI4 expression in blood and tissues of patients with malignant tumors , 2009, BMC Cancer.

[53]  A. Ishigami,et al.  Detection of deiminated proteins in rat skin: probing with a monospecific antibody after modification of citrulline residues. , 1995, The Journal of investigative dermatology.

[54]  P. Thompson,et al.  Chemical Proteomic Platform To Identify Citrullinated Proteins , 2015, ACS chemical biology.

[55]  Michael J. Bolt,et al.  Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor α target gene activation , 2012, Proceedings of the National Academy of Sciences.

[56]  W. V. van Venrooij,et al.  Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages , 2004, Annals of the rheumatic diseases.

[57]  A. Ishida-Yamamoto,et al.  Decreased deiminated keratin K1 in psoriatic hyperproliferative epidermis. , 2000, The Journal of investigative dermatology.

[58]  Alexander S. Banks,et al.  Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity , 2014, Nature.

[59]  F. V. D. van den Hoogen,et al.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. , 1998, The Journal of clinical investigation.

[60]  Zhifu Sun,et al.  Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. , 2004, The Lancet. Oncology.

[61]  Christian M. Metallo,et al.  Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis , 2012, Nature chemical biology.

[62]  K. Sugawara,et al.  Properties of peptidylarginine deiminase from the epidermis of newborn rats. , 1981, Journal of biochemistry.

[63]  Fei Wang,et al.  Identification of citrullinated peptides in the synovial fluid of patients with rheumatoid arthritis using LC-MALDI-TOF/TOF , 2016, Clinical Rheumatology.

[64]  G. Pruijn,et al.  Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis. , 2006, Autoimmunity reviews.

[65]  Anushya Muruganujan,et al.  PANTHER version 10: expanded protein families and functions, and analysis tools , 2015, Nucleic Acids Res..

[66]  S. Olson,et al.  The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation. , 2001, Biochemistry.

[67]  C. Hack,et al.  Characterization of recombinant C1 inhibitor P1 variants. , 1992, The Journal of biological chemistry.

[68]  Paul R. Thompson,et al.  Role of peptidylarginine deiminase 2 (PAD2) in mammary carcinoma cell migration , 2017, BMC Cancer.

[69]  Reinout Raijmakers,et al.  Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro. , 2007, Journal of molecular biology.

[70]  Paul R. Thompson,et al.  Chemical Biology of Protein Arginine Modifications in Epigenetic Regulation , 2015, Chemical reviews.

[71]  T. Vos,et al.  The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study , 2014, Annals of the rheumatic diseases.

[72]  P. Muñoz-Cánoves,et al.  Regulation and dysregulation of fibrosis in skeletal muscle. , 2010, Experimental cell research.

[73]  Steven Clarke,et al.  Human PAD4 Regulates Histone Arginine Methylation Levels via Demethylimination , 2004, Science.

[74]  D. Collen,et al.  Characterization of recombinant human alpha 2-antiplasmin and of mutants obtained by site-directed mutagenesis of the reactive site. , 1987, Biochemistry.

[75]  J. Hodgin,et al.  Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. , 2013, The Journal of clinical investigation.

[76]  M. Walkinshaw,et al.  M2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation , 2013, Proceedings of the National Academy of Sciences.

[77]  J. Lewis,et al.  Antithrombin Pittsburgh: an alpha1-antitrypsin variant causing hemorrhagic disease. , 1978, Blood.

[78]  S. Knapp,et al.  Citrullination-acetylation interplay guides E2F-1 activity during the inflammatory response , 2016, Science Advances.

[79]  Michael R. Lindberg,et al.  PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps , 2010, The Journal of experimental medicine.

[80]  Deepak Poudyal,et al.  Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[81]  G. Constantin,et al.  NETosis in Alzheimer’s Disease , 2017, Front. Immunol..

[82]  J. Whisstock,et al.  The Serpins Are an Expanding Superfamily of Structurally Similar but Functionally Diverse Proteins , 2001, The Journal of Biological Chemistry.

[83]  J. Norris,et al.  A molecular signature of preclinical rheumatoid arthritis triggered by dysregulated PTPN22. , 2016, JCI insight.

[84]  V. Yee,et al.  Structural basis of substrate recognition in human nicotinamide N-methyltransferase. , 2011, Biochemistry.

[85]  J. Huntington.  Serpin structure, function and dysfunction , 2011, Journal of thrombosis and haemostasis : JTH.

[86]  M. Studnicka,et al.  New Aspects on the Structure of Neutrophil Extracellular Traps from Chronic Obstructive Pulmonary Disease and In Vitro Generation , 2014, PloS one.